car t-cell
Entity, reached from Hormuz.
- Evidence
- 30 documents · 17 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 9 Oct 2026
- Measured
- 17% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- The ASCO Post · 2026-10-09 · How Does CAR T-Cell Therapy Factor in With Tafasitamab in DLBCL (opens the source in a new tab)
- Financial Post · 2026-10-08 · TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 (opens the source in a new tab)
- AllSci News · 2026-10-07 · Generate Biomedicines doses first patient in AI-designed 'armored' CAR T trial for ovarian cancer (opens the source in a new tab)
- The ASCO Post · 2026-10-05 · Relapsed or Refractory SCLC Phase I Study of Novel CAR T-Cell Therapy (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-29 · CIRM Awards Fate Therapeutics $15M for FT819 Lupus Nephritis Trial (opens the source in a new tab)
- European Medical Journal · 2026-09-24 · Fatal Inflammatory Risks Associated with CAR T-Cell Therapy (opens the source in a new tab)
- GEN · 2026-09-11 · CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration (opens the source in a new tab)
- Inside Precision Medicine · 2026-09-03 · EREG Emerges as a Potential Key Player in Pancreatic Cancer (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with car-t (30 documents)seen together
- co-mentioned with t-cell (30 documents)seen together
- co-mentioned with fda (12 documents)seen together
- co-mentioned with immunotherapy (10 documents)seen together
- co-mentioned with clinical trial (8 documents)seen together